AstraZeneca's revenue from top product Seroquel 2006-2021
In 2021, Seroquel generated 92 million U.S. dollars of revenue. This statistic describes AstraZeneca's revenue from one of its top products, Seroquel, between 2006 and 2021. AstraZeneca plc is one of the top 15 pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. In 2011, revenue from Seroquel amounted to around 5.83 billion U.S. dollars.
